- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non-Small-Cell Lung Carcinoma
Total 18552 results
-
Novartis PharmaceuticalsAvailableNon-Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Carcinoma, Non-Small Cell Lung | Non-Small-Cell Lung Carcinoma
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)WithdrawnBuparlisib, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid TumorsStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Adult Solid NeoplasmUnited States
-
Massachusetts General HospitalCompletedSmall Cell Lung Carcinoma | Non-small Cell Lung CarcinomaUnited States
-
Intergroupe Francophone de Cancerologie ThoraciqueCentre Hospitalier Universitaire de BesanconCompleted
-
Kanazawa UniversityUnknownNon-Small-Cell Lung CarcinomaJapan
-
Lyudmila Bazhenova, M.D.AstraZenecaTerminatedNon Small Cell Lung CarcinomaUnited States
-
University of Paris 5 - Rene DescartesCompleted
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CarcinomaUnited States
-
Instituto Nacional de Cancer, BrazilEli Lilly and CompanyCompletedNon Small Cell Lung CarcinomaBrazil, United States
-
AstraZenecaWithdrawn
-
AstraZenecaCompletedNon Small Cell Lung CarcinomaKorea, Republic of
-
Eisai Inc.Completed
-
St. Joseph's Healthcare HamiltonHealth Sciences Centre, Winnipeg, Manitoba; Centre hospitalier de l'Université... and other collaboratorsCompletedLung Cancer | Non Small Cell Lung Cancer | Non-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage IICanada
-
University Hospital Southampton NHS Foundation...Royal Bournemouth and Christchurch Hospitals NHS Foundation TrustUnknownNon Small Cell Lung Cancer | Non Small Cell Lung Cancer Stage IIIB | Non Small Cell Lung Cancer MetastaticUnited Kingdom
-
Gene SolutionsRecruitingNon Small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Stage IIIC Non-Small Cell Lung Cancer | Tyrosine Kinase InhibitorsVietnam
-
University of WashingtonNational Cancer Institute (NCI)TerminatedStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Zhejiang UniversityRecruitingUnresectable Lung Non-Small Cell CarcinomaChina
-
Regeneron PharmaceuticalsSanofiTerminatedAdvanced Non-Small Cell Lung CarcinomaUnited States, Belgium, France, Germany, Korea, Republic of, Poland, Spain, Taiwan, United Kingdom
-
AstraZenecaActive, not recruitingNon-Small-Cell Lung CarcinomaFrance, Spain, Thailand, Belgium, Korea, Republic of, Netherlands, United States, Brazil, Japan, China, Malaysia, Taiwan, Australia, Denmark
-
Duke UniversityCompletedNon-small Cell Lung CarcinomaUnited States
-
TransgeneTerminatedNon-Small-Cell Lung CarcinomaUnited States, France, Hungary, United Kingdom, Spain, Israel, Belgium, Germany, Poland, Italy
-
Novartis PharmaceuticalsCompletedNon-small-cell Lung CarcinomaUnited States
-
University of CologneCompleted
-
SanofiTerminated
-
Maastricht Radiation OncologyPfizerCompletedNon Small Cell Lung CarcinomaNetherlands
-
Maastricht Radiation OncologyCompletedNon-Small-Cell Lung CarcinomaNetherlands
-
Aktion Bronchialkarzinom e.V.CompletedNon-Small-Cell Lung CarcinomaGermany
-
TelikCompletedStudy of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung CancerNon Small Cell Lung CarcinomaUnited States, Australia, Brazil, Chile, Germany, Argentina, Italy, United Kingdom
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CarcinomaUnited States
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CarcinomaArgentina, Brazil, Chile, Mexico
-
Shenzhen People's HospitalUnknownCarcinoma, Non-Small Cell Lung | Carcinoma, Small Cell LungChina
-
ElephasBeaufort CRORecruitingNSCLC | Non Small Cell Lung Cancer | Metastatic Non Small Cell Lung Cancer | Metastatic NSCLC - Non-Small Cell Lung CancerUnited States
-
Mahmut GumusActive, not recruitingNon Small Cell Lung Cancer | Small-cell Lung CancerTurkey
-
Bristol-Myers SquibbNo longer availableNon-squamous Non-Small Cell Lung Cancer | Squamous Non-Small Cell Lung CancerBrazil, Canada
-
Joel NealMerck Sharp & Dohme LLCActive, not recruitingMetastatic Non-Squamous Non-Small Cell Lung CarcinomaUnited States
-
Centre Hospitalier Universitaire, AmiensUnknownNon Small Cells Lung CancerFrance
-
Tufts Medical CenterPartner Therapeutics, Inc.RecruitingAdvanced Lung Non-Small Cell Carcinoma | Non-Small Cell Carcinoma of Lung, TNM Stage 4United States
-
Maximilian DiehnVarian Medical SystemsCompletedStage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States
-
NeoImmuneTechRoche Pharma AGActive, not recruitingCarcinoma, Non-Small-Cell Lung | Non-Small Cell Lung Cancer | Non Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Non-Small Cell Lung CarcinomaUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Center Trials & Treatment EuropeCenter Trials & TreatmentActive, not recruitingNon Small Cell Lung CancerGeorgia
-
Peter MacCallum Cancer Centre, AustraliaCompletedNon-small Cell Lung CancerAustralia, Canada
-
National Cancer Institute (NCI)CompletedNon-Small-Cell Lung CarcinomaUnited States, Mexico, Bolivia, Peru, Venezuela
-
National Cancer Institute (NCI)University of Chicago; City of Hope Medical Center; University of Southern California and other collaboratorsCompleted
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CarcinomaUnited States
-
University Hospital, BordeauxCompletedLung Cancer | Non-small-cell Lung CarcinomaFrance
-
Genentech, Inc.CompletedLung Cancer | Non-small-cell Lung CarcinomaUnited States
-
Bristol-Myers SquibbTerminatedNon Small Cell Lung CancerUnited States
-
AstraZenecaCompletedNon Small Cell Lung CarcinomaAustralia